STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial
🌐 Source: Statnews • 📅 17 Nov 2026 • ⏱️ 1 min read (15 words, ⚡ Quick Read)
STAT Plus: What to know about Biogen’s big lupus study readout
→ Read original article